BlueRock Therapeutics is at the forefront of cellular therapy, dedicated to developing groundbreaking medicines that significantly improve patients' lives suffering from neurological and ophthalmological disease. We are seeking a highly collaborative and dynamic individual to join our New York City site (in person) as a Preclinical Program Lead, Retinal Cell Therapies and Translational Neuroscience. The role has two primary focus areas in acting as Program Lead for the OpCT-002/003 preclinical program and Translational Neuroscience Coordinator for BlueRock’s preclinical assets. Reporting directly to the CSO, this role will be instrumental in advancing our cell+gene pipeline. This role requires significant industry experience and specific, deep knowledge of retinal cell biology, along with demonstrated clinical development experience.

This is an ideal opportunity for a clinical developer who is passionate about research, or vice versa, eager to bridge the gap between early discovery and patient impact.

This is an exceptional opportunity for a talented scientist to make a tangible impact on a new class of medicines and gain invaluable career experience within the cell therapy field. You'll join a highly motivated, world-class team of scientists and engineers in an exciting and engaging work environment.